nodes	percent_of_prediction	percent_of_DWPC	metapath
Agomelatine—MTNR1A—blood—hypothyroidism	0.0284	0.164	CbGeAlD
Agomelatine—Irritability—Dextrothyroxine—hypothyroidism	0.0269	0.0388	CcSEcCtD
Agomelatine—Irritability—Levothyroxine—hypothyroidism	0.0269	0.0388	CcSEcCtD
Agomelatine—MTNR1A—testis—hypothyroidism	0.0235	0.135	CbGeAlD
Agomelatine—CYP1A2—urine—hypothyroidism	0.0233	0.134	CbGeAlD
Agomelatine—CYP2C9—urine—hypothyroidism	0.0221	0.128	CbGeAlD
Agomelatine—Weight decreased—Dextrothyroxine—hypothyroidism	0.0221	0.0318	CcSEcCtD
Agomelatine—Weight decreased—Levothyroxine—hypothyroidism	0.0221	0.0318	CcSEcCtD
Agomelatine—Irritability—Liotrix—hypothyroidism	0.0198	0.0285	CcSEcCtD
Agomelatine—Weight decreased—Liotrix—hypothyroidism	0.0162	0.0234	CcSEcCtD
Agomelatine—Tremor—Levothyroxine—hypothyroidism	0.0159	0.0229	CcSEcCtD
Agomelatine—Tremor—Dextrothyroxine—hypothyroidism	0.0159	0.0229	CcSEcCtD
Agomelatine—Agitation—Levothyroxine—hypothyroidism	0.0156	0.0225	CcSEcCtD
Agomelatine—Agitation—Dextrothyroxine—hypothyroidism	0.0156	0.0225	CcSEcCtD
Agomelatine—Angioedema—Levothyroxine—hypothyroidism	0.0155	0.0224	CcSEcCtD
Agomelatine—Angioedema—Dextrothyroxine—hypothyroidism	0.0155	0.0224	CcSEcCtD
Agomelatine—Anxiety—Levothyroxine—hypothyroidism	0.0144	0.0208	CcSEcCtD
Agomelatine—Anxiety—Dextrothyroxine—hypothyroidism	0.0144	0.0208	CcSEcCtD
Agomelatine—Hyperhidrosis—Dextrothyroxine—hypothyroidism	0.0134	0.0193	CcSEcCtD
Agomelatine—Hyperhidrosis—Levothyroxine—hypothyroidism	0.0134	0.0193	CcSEcCtD
Agomelatine—Insomnia—Levothyroxine—hypothyroidism	0.0125	0.0181	CcSEcCtD
Agomelatine—Insomnia—Dextrothyroxine—hypothyroidism	0.0125	0.0181	CcSEcCtD
Agomelatine—Fatigue—Dextrothyroxine—hypothyroidism	0.012	0.0172	CcSEcCtD
Agomelatine—Fatigue—Levothyroxine—hypothyroidism	0.012	0.0172	CcSEcCtD
Agomelatine—Vision blurred—Liotrix—hypothyroidism	0.0118	0.017	CcSEcCtD
Agomelatine—Tremor—Liotrix—hypothyroidism	0.0117	0.0169	CcSEcCtD
Agomelatine—Agitation—Liotrix—hypothyroidism	0.0115	0.0166	CcSEcCtD
Agomelatine—Angioedema—Liotrix—hypothyroidism	0.0114	0.0165	CcSEcCtD
Agomelatine—Gastrointestinal pain—Levothyroxine—hypothyroidism	0.0113	0.0163	CcSEcCtD
Agomelatine—Gastrointestinal pain—Dextrothyroxine—hypothyroidism	0.0113	0.0163	CcSEcCtD
Agomelatine—Urticaria—Dextrothyroxine—hypothyroidism	0.011	0.0159	CcSEcCtD
Agomelatine—Urticaria—Levothyroxine—hypothyroidism	0.011	0.0159	CcSEcCtD
Agomelatine—Abdominal pain—Levothyroxine—hypothyroidism	0.011	0.0158	CcSEcCtD
Agomelatine—Abdominal pain—Dextrothyroxine—hypothyroidism	0.011	0.0158	CcSEcCtD
Agomelatine—Anxiety—Liotrix—hypothyroidism	0.0106	0.0153	CcSEcCtD
Agomelatine—Infection—Liotrix—hypothyroidism	0.0101	0.0146	CcSEcCtD
Agomelatine—Asthenia—Dextrothyroxine—hypothyroidism	0.00996	0.0143	CcSEcCtD
Agomelatine—Asthenia—Levothyroxine—hypothyroidism	0.00996	0.0143	CcSEcCtD
Agomelatine—Hyperhidrosis—Liotrix—hypothyroidism	0.00987	0.0142	CcSEcCtD
Agomelatine—Pruritus—Dextrothyroxine—hypothyroidism	0.00982	0.0141	CcSEcCtD
Agomelatine—Pruritus—Levothyroxine—hypothyroidism	0.00982	0.0141	CcSEcCtD
Agomelatine—Diarrhoea—Dextrothyroxine—hypothyroidism	0.00949	0.0137	CcSEcCtD
Agomelatine—Diarrhoea—Levothyroxine—hypothyroidism	0.00949	0.0137	CcSEcCtD
Agomelatine—Insomnia—Liotrix—hypothyroidism	0.00923	0.0133	CcSEcCtD
Agomelatine—Paraesthesia—Liotrix—hypothyroidism	0.00916	0.0132	CcSEcCtD
Agomelatine—HTR2B—adrenal cortex—hypothyroidism	0.00904	0.0521	CbGeAlD
Agomelatine—Vomiting—Dextrothyroxine—hypothyroidism	0.00882	0.0127	CcSEcCtD
Agomelatine—Vomiting—Levothyroxine—hypothyroidism	0.00882	0.0127	CcSEcCtD
Agomelatine—Fatigue—Liotrix—hypothyroidism	0.0088	0.0127	CcSEcCtD
Agomelatine—HTR2B—heart—hypothyroidism	0.00874	0.0504	CbGeAlD
Agomelatine—Constipation—Liotrix—hypothyroidism	0.00873	0.0126	CcSEcCtD
Agomelatine—Headache—Dextrothyroxine—hypothyroidism	0.00869	0.0125	CcSEcCtD
Agomelatine—Headache—Levothyroxine—hypothyroidism	0.00869	0.0125	CcSEcCtD
Agomelatine—Gastrointestinal pain—Liotrix—hypothyroidism	0.00835	0.012	CcSEcCtD
Agomelatine—HTR2B—cardiovascular system—hypothyroidism	0.00825	0.0476	CbGeAlD
Agomelatine—Nausea—Dextrothyroxine—hypothyroidism	0.00824	0.0119	CcSEcCtD
Agomelatine—Nausea—Levothyroxine—hypothyroidism	0.00824	0.0119	CcSEcCtD
Agomelatine—Urticaria—Liotrix—hypothyroidism	0.00811	0.0117	CcSEcCtD
Agomelatine—Abdominal pain—Liotrix—hypothyroidism	0.00807	0.0116	CcSEcCtD
Agomelatine—Asthenia—Liotrix—hypothyroidism	0.00732	0.0105	CcSEcCtD
Agomelatine—Pruritus—Liotrix—hypothyroidism	0.00722	0.0104	CcSEcCtD
Agomelatine—Diarrhoea—Liotrix—hypothyroidism	0.00698	0.0101	CcSEcCtD
Agomelatine—Dizziness—Liotrix—hypothyroidism	0.00675	0.00972	CcSEcCtD
Agomelatine—HTR2B—adrenal gland—hypothyroidism	0.00652	0.0376	CbGeAlD
Agomelatine—HTR2B—blood—hypothyroidism	0.00652	0.0376	CbGeAlD
Agomelatine—MTNR1A—Circadian rythm related genes—NKX2-1—hypothyroidism	0.0065	0.0491	CbGpPWpGaD
Agomelatine—MTNR1B—Circadian rythm related genes—NKX2-1—hypothyroidism	0.0065	0.0491	CbGpPWpGaD
Agomelatine—Vomiting—Liotrix—hypothyroidism	0.00649	0.00935	CcSEcCtD
Agomelatine—Headache—Liotrix—hypothyroidism	0.00639	0.00921	CcSEcCtD
Agomelatine—HTR2B—thyroid gland—hypothyroidism	0.00629	0.0363	CbGeAlD
Agomelatine—Nausea—Liotrix—hypothyroidism	0.00606	0.00873	CcSEcCtD
Agomelatine—CYP2C9—heart—hypothyroidism	0.00567	0.0327	CbGeAlD
Agomelatine—CYP2C9—cardiovascular system—hypothyroidism	0.00535	0.0308	CbGeAlD
Agomelatine—CYP1A2—blood—hypothyroidism	0.00445	0.0257	CbGeAlD
Agomelatine—CYP1A2—thyroid gland—hypothyroidism	0.0043	0.0248	CbGeAlD
Agomelatine—CYP2C9—blood—hypothyroidism	0.00423	0.0244	CbGeAlD
Agomelatine—CYP1A2—liver—hypothyroidism	0.00348	0.0201	CbGeAlD
Agomelatine—CYP2C9—liver—hypothyroidism	0.00331	0.0191	CbGeAlD
Agomelatine—MTNR1A—Class A/1 (Rhodopsin-like receptors)—TRH—hypothyroidism	0.00329	0.0249	CbGpPWpGaD
Agomelatine—MTNR1B—Class A/1 (Rhodopsin-like receptors)—TRH—hypothyroidism	0.00329	0.0249	CbGpPWpGaD
Agomelatine—MTNR1B—Class A/1 (Rhodopsin-like receptors)—TSHB—hypothyroidism	0.00294	0.0222	CbGpPWpGaD
Agomelatine—MTNR1A—Class A/1 (Rhodopsin-like receptors)—TSHB—hypothyroidism	0.00294	0.0222	CbGpPWpGaD
Agomelatine—MTNR1B—Class A/1 (Rhodopsin-like receptors)—TSHR—hypothyroidism	0.00294	0.0222	CbGpPWpGaD
Agomelatine—MTNR1A—Class A/1 (Rhodopsin-like receptors)—TSHR—hypothyroidism	0.00294	0.0222	CbGpPWpGaD
Agomelatine—MTNR1B—GPCR ligand binding—TRH—hypothyroidism	0.00251	0.019	CbGpPWpGaD
Agomelatine—MTNR1A—GPCR ligand binding—TRH—hypothyroidism	0.00251	0.019	CbGpPWpGaD
Agomelatine—MTNR1A—Circadian rythm related genes—AVP—hypothyroidism	0.00247	0.0186	CbGpPWpGaD
Agomelatine—MTNR1B—Circadian rythm related genes—AVP—hypothyroidism	0.00247	0.0186	CbGpPWpGaD
Agomelatine—MTNR1B—GPCR ligand binding—TSHB—hypothyroidism	0.00224	0.0169	CbGpPWpGaD
Agomelatine—MTNR1A—GPCR ligand binding—TSHB—hypothyroidism	0.00224	0.0169	CbGpPWpGaD
Agomelatine—MTNR1B—GPCR ligand binding—TSHR—hypothyroidism	0.00224	0.0169	CbGpPWpGaD
Agomelatine—MTNR1A—GPCR ligand binding—TSHR—hypothyroidism	0.00224	0.0169	CbGpPWpGaD
Agomelatine—MTNR1A—Class A/1 (Rhodopsin-like receptors)—AVP—hypothyroidism	0.00173	0.0131	CbGpPWpGaD
Agomelatine—MTNR1B—Class A/1 (Rhodopsin-like receptors)—AVP—hypothyroidism	0.00173	0.0131	CbGpPWpGaD
Agomelatine—HTR2B—G alpha (q) signalling events—TRH—hypothyroidism	0.00161	0.0121	CbGpPWpGaD
Agomelatine—MTNR1B—G alpha (i) signalling events—POMC—hypothyroidism	0.00145	0.0109	CbGpPWpGaD
Agomelatine—MTNR1A—G alpha (i) signalling events—POMC—hypothyroidism	0.00145	0.0109	CbGpPWpGaD
Agomelatine—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—TRH—hypothyroidism	0.00144	0.0109	CbGpPWpGaD
Agomelatine—MTNR1B—GPCR downstream signaling—TRH—hypothyroidism	0.00142	0.0107	CbGpPWpGaD
Agomelatine—MTNR1A—GPCR downstream signaling—TRH—hypothyroidism	0.00142	0.0107	CbGpPWpGaD
Agomelatine—MTNR1A—GPCR ligand binding—AVP—hypothyroidism	0.00132	0.00996	CbGpPWpGaD
Agomelatine—MTNR1B—GPCR ligand binding—AVP—hypothyroidism	0.00132	0.00996	CbGpPWpGaD
Agomelatine—HTR2C—G alpha (q) signalling events—TRH—hypothyroidism	0.0013	0.00979	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling by GPCR—TRH—hypothyroidism	0.00129	0.00973	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling by GPCR—TRH—hypothyroidism	0.00129	0.00973	CbGpPWpGaD
Agomelatine—MTNR1B—GPCR downstream signaling—TSHB—hypothyroidism	0.00126	0.00955	CbGpPWpGaD
Agomelatine—MTNR1A—GPCR downstream signaling—TSHB—hypothyroidism	0.00126	0.00955	CbGpPWpGaD
Agomelatine—MTNR1A—GPCR downstream signaling—TSHR—hypothyroidism	0.00126	0.00955	CbGpPWpGaD
Agomelatine—MTNR1B—GPCR downstream signaling—TSHR—hypothyroidism	0.00126	0.00955	CbGpPWpGaD
Agomelatine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—TRH—hypothyroidism	0.00116	0.00876	CbGpPWpGaD
Agomelatine—MTNR1B—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	0.00115	0.00869	CbGpPWpGaD
Agomelatine—MTNR1A—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	0.00115	0.00869	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling by GPCR—TSHB—hypothyroidism	0.00115	0.00867	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling by GPCR—TSHR—hypothyroidism	0.00115	0.00867	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling by GPCR—TSHR—hypothyroidism	0.00115	0.00867	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling by GPCR—TSHB—hypothyroidism	0.00115	0.00867	CbGpPWpGaD
Agomelatine—HTR2B—Class A/1 (Rhodopsin-like receptors)—TRH—hypothyroidism	0.00106	0.00804	CbGpPWpGaD
Agomelatine—HTR2B—Class A/1 (Rhodopsin-like receptors)—TSHB—hypothyroidism	0.000948	0.00717	CbGpPWpGaD
Agomelatine—HTR2B—Class A/1 (Rhodopsin-like receptors)—TSHR—hypothyroidism	0.000948	0.00717	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—CLTC—hypothyroidism	0.00088	0.00665	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—CLTC—hypothyroidism	0.00088	0.00665	CbGpPWpGaD
Agomelatine—MTNR1A—GPCR ligand binding—POMC—hypothyroidism	0.000876	0.00662	CbGpPWpGaD
Agomelatine—MTNR1B—GPCR ligand binding—POMC—hypothyroidism	0.000876	0.00662	CbGpPWpGaD
Agomelatine—HTR2C—Class A/1 (Rhodopsin-like receptors)—TRH—hypothyroidism	0.000858	0.00649	CbGpPWpGaD
Agomelatine—HTR2B—G alpha (q) signalling events—AVP—hypothyroidism	0.000844	0.00638	CbGpPWpGaD
Agomelatine—HTR2B—GPCR ligand binding—TRH—hypothyroidism	0.00081	0.00612	CbGpPWpGaD
Agomelatine—MTNR1B—GPCR downstream signaling—VAV3—hypothyroidism	0.000773	0.00584	CbGpPWpGaD
Agomelatine—MTNR1A—GPCR downstream signaling—VAV3—hypothyroidism	0.000773	0.00584	CbGpPWpGaD
Agomelatine—HTR2C—Class A/1 (Rhodopsin-like receptors)—TSHB—hypothyroidism	0.000765	0.00578	CbGpPWpGaD
Agomelatine—HTR2C—Class A/1 (Rhodopsin-like receptors)—TSHR—hypothyroidism	0.000765	0.00578	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—TRH—hypothyroidism	0.000761	0.00575	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—TRH—hypothyroidism	0.000761	0.00575	CbGpPWpGaD
Agomelatine—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—AVP—hypothyroidism	0.000755	0.0057	CbGpPWpGaD
Agomelatine—MTNR1A—GPCR downstream signaling—AVP—hypothyroidism	0.000745	0.00563	CbGpPWpGaD
Agomelatine—MTNR1B—GPCR downstream signaling—AVP—hypothyroidism	0.000745	0.00563	CbGpPWpGaD
Agomelatine—HTR2B—GPCR ligand binding—TSHB—hypothyroidism	0.000722	0.00546	CbGpPWpGaD
Agomelatine—HTR2B—GPCR ligand binding—TSHR—hypothyroidism	0.000722	0.00546	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling by GPCR—VAV3—hypothyroidism	0.000702	0.00531	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling by GPCR—VAV3—hypothyroidism	0.000702	0.00531	CbGpPWpGaD
Agomelatine—HTR2C—G alpha (q) signalling events—AVP—hypothyroidism	0.000681	0.00514	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—TSHB—hypothyroidism	0.000678	0.00512	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—TSHB—hypothyroidism	0.000678	0.00512	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—TSHR—hypothyroidism	0.000678	0.00512	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—TSHR—hypothyroidism	0.000678	0.00512	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling by GPCR—AVP—hypothyroidism	0.000676	0.00511	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling by GPCR—AVP—hypothyroidism	0.000676	0.00511	CbGpPWpGaD
Agomelatine—HTR2C—GPCR ligand binding—TRH—hypothyroidism	0.000653	0.00494	CbGpPWpGaD
Agomelatine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—AVP—hypothyroidism	0.000609	0.0046	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—SH2B3—hypothyroidism	0.000604	0.00457	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—SH2B3—hypothyroidism	0.000604	0.00457	CbGpPWpGaD
Agomelatine—HTR2C—GPCR ligand binding—TSHB—hypothyroidism	0.000582	0.0044	CbGpPWpGaD
Agomelatine—HTR2C—GPCR ligand binding—TSHR—hypothyroidism	0.000582	0.0044	CbGpPWpGaD
Agomelatine—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.000573	0.00433	CbGpPWpGaD
Agomelatine—HTR2B—Class A/1 (Rhodopsin-like receptors)—AVP—hypothyroidism	0.000559	0.00422	CbGpPWpGaD
Agomelatine—MTNR1A—GPCR downstream signaling—POMC—hypothyroidism	0.000495	0.00374	CbGpPWpGaD
Agomelatine—MTNR1B—GPCR downstream signaling—POMC—hypothyroidism	0.000495	0.00374	CbGpPWpGaD
Agomelatine—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.00049	0.0037	CbGpPWpGaD
Agomelatine—CYP2C9—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.000465	0.00351	CbGpPWpGaD
Agomelatine—HTR2B—GPCR downstream signaling—TRH—hypothyroidism	0.000458	0.00346	CbGpPWpGaD
Agomelatine—HTR2C—Class A/1 (Rhodopsin-like receptors)—AVP—hypothyroidism	0.000451	0.00341	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling by GPCR—POMC—hypothyroidism	0.000449	0.0034	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling by GPCR—POMC—hypothyroidism	0.000449	0.0034	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—PRL—hypothyroidism	0.000448	0.00339	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—PRL—hypothyroidism	0.000448	0.00339	CbGpPWpGaD
Agomelatine—HTR2B—GPCR ligand binding—AVP—hypothyroidism	0.000425	0.00322	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—TRH—hypothyroidism	0.000416	0.00314	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—VAV3—hypothyroidism	0.000415	0.00313	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—VAV3—hypothyroidism	0.000415	0.00313	CbGpPWpGaD
Agomelatine—HTR2B—GPCR downstream signaling—TSHB—hypothyroidism	0.000408	0.00308	CbGpPWpGaD
Agomelatine—HTR2B—GPCR downstream signaling—TSHR—hypothyroidism	0.000408	0.00308	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—AVP—hypothyroidism	0.0004	0.00302	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—AVP—hypothyroidism	0.0004	0.00302	CbGpPWpGaD
Agomelatine—CYP1A2—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.000397	0.003	CbGpPWpGaD
Agomelatine—HTR2B—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	0.000371	0.00281	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—TSHR—hypothyroidism	0.00037	0.0028	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—TSHB—hypothyroidism	0.00037	0.0028	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—TRH—hypothyroidism	0.000369	0.00279	CbGpPWpGaD
Agomelatine—HTR2C—GPCR ligand binding—AVP—hypothyroidism	0.000343	0.00259	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—TRH—hypothyroidism	0.000335	0.00253	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—TSHB—hypothyroidism	0.000329	0.00249	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—TSHR—hypothyroidism	0.000329	0.00249	CbGpPWpGaD
Agomelatine—HTR2C—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	0.0003	0.00226	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—TSHB—hypothyroidism	0.000299	0.00226	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—TSHR—hypothyroidism	0.000299	0.00226	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—IYD—hypothyroidism	0.000291	0.0022	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—CLTC—hypothyroidism	0.000284	0.00215	CbGpPWpGaD
Agomelatine—HTR2B—GPCR ligand binding—POMC—hypothyroidism	0.000283	0.00214	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—POMC—hypothyroidism	0.000266	0.00201	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—POMC—hypothyroidism	0.000266	0.00201	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—IGF1—hypothyroidism	0.000255	0.00193	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—IGF1—hypothyroidism	0.000255	0.00193	CbGpPWpGaD
Agomelatine—HTR2B—GPCR downstream signaling—VAV3—hypothyroidism	0.00025	0.00189	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—IYD—hypothyroidism	0.000249	0.00188	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—ATP5O—hypothyroidism	0.000248	0.00187	CbGpPWpGaD
Agomelatine—CYP2C9—Biological oxidations—POMC—hypothyroidism	0.000247	0.00187	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—TRH—hypothyroidism	0.000246	0.00186	CbGpPWpGaD
Agomelatine—HTR2B—GPCR downstream signaling—AVP—hypothyroidism	0.00024	0.00182	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—TPO—hypothyroidism	0.000233	0.00176	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—CLTC—hypothyroidism	0.000229	0.00173	CbGpPWpGaD
Agomelatine—HTR2C—GPCR ligand binding—POMC—hypothyroidism	0.000228	0.00172	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—VAV3—hypothyroidism	0.000227	0.00171	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—TSHB—hypothyroidism	0.000219	0.00165	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—TSHR—hypothyroidism	0.000219	0.00165	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—AVP—hypothyroidism	0.000218	0.00165	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	0.000216	0.00163	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—ATP5O—hypothyroidism	0.000212	0.0016	CbGpPWpGaD
Agomelatine—CYP1A2—Biological oxidations—POMC—hypothyroidism	0.000211	0.00159	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—VAV3—hypothyroidism	0.000201	0.00152	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—TPO—hypothyroidism	0.000199	0.0015	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—TRH—hypothyroidism	0.000198	0.0015	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—SH2B3—hypothyroidism	0.000195	0.00147	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—AVP—hypothyroidism	0.000194	0.00147	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	0.000184	0.00139	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—VAV3—hypothyroidism	0.000183	0.00138	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—TSHR—hypothyroidism	0.000177	0.00133	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—TSHB—hypothyroidism	0.000177	0.00133	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—AVP—hypothyroidism	0.000176	0.00133	CbGpPWpGaD
Agomelatine—HTR2B—GPCR downstream signaling—POMC—hypothyroidism	0.00016	0.00121	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—SH2B3—hypothyroidism	0.000157	0.00119	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—POMC—hypothyroidism	0.000145	0.0011	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—PRL—hypothyroidism	0.000145	0.00109	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—VAV3—hypothyroidism	0.000134	0.00101	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—AVP—hypothyroidism	0.000129	0.000975	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—POMC—hypothyroidism	0.000129	0.000974	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—POMC—hypothyroidism	0.000117	0.000885	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—PRL—hypothyroidism	0.000117	0.000883	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—VAV3—hypothyroidism	0.000108	0.000816	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—TSHB—hypothyroidism	0.000108	0.000815	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—AVP—hypothyroidism	0.000104	0.000787	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—PIK3C2A—hypothyroidism	9.61e-05	0.000726	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	9.48e-05	0.000716	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—TSHB—hypothyroidism	9.21e-05	0.000696	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—POMC—hypothyroidism	8.57e-05	0.000648	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—IGF1—hypothyroidism	8.24e-05	0.000623	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—PIK3C2A—hypothyroidism	8.21e-05	0.00062	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	8.1e-05	0.000612	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—SLC5A5—hypothyroidism	8.07e-05	0.00061	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—POMC—hypothyroidism	6.92e-05	0.000523	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—SLC5A5—hypothyroidism	6.89e-05	0.000521	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—IGF1—hypothyroidism	6.65e-05	0.000503	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—POMC—hypothyroidism	4.22e-05	0.000319	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—POMC—hypothyroidism	3.61e-05	0.000273	CbGpPWpGaD
